Icu Medical Inc (ICUI)

$162.32

+1.13

(+0.7%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $160.90
    $165.15
    $162.32
    downward going graph

    0.87%

    Downside

    Day's Volatility :2.57%

    Upside

    1.71%

    downward going graph
  • $78.28
    $166.46
    $162.32
    downward going graph

    51.77%

    Downside

    52 Weeks Volatility :52.97%

    Upside

    2.49%

    downward going graph

Returns

PeriodIcu Medical IncSector (Health Care)Index (Russel 2000)
3 Months
44.71%
5.1%
0.0%
6 Months
54.02%
4.9%
0.0%
1 Year
20.89%
16.6%
0.0%
3 Years
-21.2%
13.2%
-22.3%

Highlights

Market Capitalization
4.0B
Book Value
$83.43
Earnings Per Share (EPS)
-2.92
PEG Ratio
1.61
Wall Street Target Price
147.75
Profit Margin
-3.07%
Operating Margin TTM
4.11%
Return On Assets TTM
0.56%
Return On Equity TTM
-3.41%
Revenue TTM
2.3B
Revenue Per Share TTM
95.16
Quarterly Revenue Growth YOY
8.6%
Gross Profit TTM
697.8M
EBITDA
265.6M
Diluted Eps TTM
-2.92
Quarterly Earnings Growth YOY
-0.24
EPS Estimate Current Year
5.19
EPS Estimate Next Year
6.82
EPS Estimate Current Quarter
1.0
EPS Estimate Next Quarter
1.32

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Icu Medical Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 8.98%

Current $162.32
Target $147.75

Company Financials

FY18Y/Y Change
Revenue
1.4B
↑ 8.31%
Net Income
28.8M
↓ 58.05%
Net Profit Margin
2.06%
↓ 3.25%
FY19Y/Y Change
Revenue
1.3B
↓ 9.56%
Net Income
101.0M
↑ 250.9%
Net Profit Margin
7.98%
↑ 5.92%
FY20Y/Y Change
Revenue
1.3B
↑ 0.38%
Net Income
86.9M
↓ 14.02%
Net Profit Margin
6.83%
↓ 1.15%
FY21Y/Y Change
Revenue
1.3B
↑ 3.56%
Net Income
103.1M
↑ 18.72%
Net Profit Margin
7.84%
↑ 1.01%
FY22Y/Y Change
Revenue
2.3B
↑ 73.21%
Net Income
-74.3M
↓ 172.03%
Net Profit Margin
-3.26%
↓ 11.1%
FY23Y/Y Change
Revenue
2.3B
↓ 0.93%
Net Income
-29.7M
↓ 60.08%
Net Profit Margin
-1.31%
↑ 1.95%
Q1 FY23Q/Q Change
Revenue
568.6M
↓ 1.62%
Net Income
-9.8M
↓ 36.84%
Net Profit Margin
-1.73%
↑ 0.96%
Q2 FY23Q/Q Change
Revenue
549.3M
↓ 3.4%
Net Income
-9.9M
↑ 1.24%
Net Profit Margin
-1.81%
↓ 0.08%
Q3 FY23Q/Q Change
Revenue
553.3M
↑ 0.73%
Net Income
7.2M
↓ 172.86%
Net Profit Margin
1.31%
↑ 3.12%
Q4 FY23Q/Q Change
Revenue
588.0M
↑ 6.27%
Net Income
-17.1M
↓ 336.9%
Net Profit Margin
-2.92%
↓ 4.23%
Q1 FY24Q/Q Change
Revenue
566.0M
↓ 3.75%
Net Income
-39.5M
↑ 130.19%
Net Profit Margin
-6.97%
↓ 4.05%
Q2 FY24Q/Q Change
Revenue
595.8M
↑ 5.28%
Net Income
-21.4M
↓ 45.77%
Net Profit Margin
-3.59%
↑ 3.38%
FY18Y/Y Change
Total Assets
1.6B
↑ 5.91%
Total Liabilities
321.7M
↑ 7.71%
FY19Y/Y Change
Total Assets
1.7B
↑ 6.75%
Total Liabilities
315.1M
↓ 2.05%
FY20Y/Y Change
Total Assets
1.8B
↑ 4.21%
Total Liabilities
261.4M
↓ 17.04%
FY21Y/Y Change
Total Assets
1.9B
↑ 6.64%
Total Liabilities
264.7M
↑ 1.26%
FY22Y/Y Change
Total Assets
4.5B
↑ 140.1%
Total Liabilities
2.4B
↑ 816.38%
FY23Y/Y Change
Total Assets
4.4B
↓ 3.04%
Total Liabilities
2.3B
↓ 7.04%
Q1 FY23Q/Q Change
Total Assets
4.5B
↓ 1.0%
Total Liabilities
2.4B
↓ 2.29%
Q2 FY23Q/Q Change
Total Assets
4.5B
↓ 0.17%
Total Liabilities
2.3B
↓ 0.93%
Q3 FY23Q/Q Change
Total Assets
4.4B
↓ 1.93%
Total Liabilities
2.3B
↓ 2.97%
Q4 FY23Q/Q Change
Total Assets
4.4B
↑ 0.04%
Total Liabilities
2.3B
↓ 1.03%
Q1 FY24Q/Q Change
Total Assets
4.3B
↓ 2.06%
Total Liabilities
2.2B
↓ 1.53%
Q2 FY24Q/Q Change
Total Assets
4.3B
↓ 0.04%
Total Liabilities
2.2B
↑ 1.27%
FY18Y/Y Change
Operating Cash Flow
160.2M
↑ 3.75%
Investing Cash Flow
-103.4M
↓ 61.27%
Financing Cash Flow
8.0M
↓ 118.09%
FY19Y/Y Change
Operating Cash Flow
101.9M
↓ 36.39%
Investing Cash Flow
-166.9M
↑ 61.45%
Financing Cash Flow
-10.9M
↓ 235.95%
FY20Y/Y Change
Operating Cash Flow
222.8M
↑ 118.56%
Investing Cash Flow
-98.1M
↓ 41.19%
Financing Cash Flow
-40.0K
↓ 99.63%
FY21Y/Y Change
Operating Cash Flow
267.5M
↑ 20.11%
Investing Cash Flow
-90.7M
↓ 7.59%
Financing Cash Flow
-16.9M
↑ 42075.0%
FY22Y/Y Change
Operating Cash Flow
-62.1M
↓ 123.22%
Investing Cash Flow
-1.9B
↑ 2005.56%
Financing Cash Flow
1.6B
↓ 9803.81%
Q1 FY23Q/Q Change
Operating Cash Flow
41.2M
↓ 2510.58%
Investing Cash Flow
-15.2M
↓ 36.73%
Financing Cash Flow
-15.8M
↑ 52.5%
Q2 FY23Q/Q Change
Operating Cash Flow
-1.5M
↓ 103.57%
Investing Cash Flow
-17.6M
↑ 15.96%
Financing Cash Flow
-5.9M
↓ 62.76%

Technicals Summary

Sell

Neutral

Buy

Icu Medical Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Icu Medical Inc
Icu Medical Inc
33.28%
54.02%
20.89%
-21.2%
3.59%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
5.02%
20.15%
58.74%
31.28%
184.98%
Resmed Inc.
Resmed Inc.
16.09%
27.14%
62.7%
-17.28%
81.24%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.02%
-2.08%
-12.88%
-9.76%
-9.75%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
1.18%
-17.93%
-26.4%
-35.64%
104.36%
Alcon Ag
Alcon Ag
3.83%
8.9%
15.02%
11.44%
61.54%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Icu Medical Inc
Icu Medical Inc
356.69
NA
1.61
5.19
-0.03
0.01
NA
83.43
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
81.91
81.91
4.06
6.65
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
35.33
35.33
2.05
7.71
0.23
0.13
0.01
33.11
Becton, Dickinson And Company
Becton, Dickinson And Company
46.72
46.72
1.08
13.11
0.06
0.03
0.02
89.5
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
5.15
6.51
0.2
0.11
0.0
35.49
Alcon Ag
Alcon Ag
42.64
42.64
3.53
3.05
0.05
0.03
0.0
42.35
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Icu Medical Inc
Icu Medical Inc
Buy
$4.0B
3.59%
356.69
-3.07%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$169.4B
184.98%
81.91
27.65%
Resmed Inc.
Resmed Inc.
Buy
$36.0B
81.24%
35.33
21.79%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.4B
-9.75%
46.72
7.13%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$21.8B
104.36%
42.71
18.25%
Alcon Ag
Alcon Ag
Buy
$46.7B
61.54%
42.64
11.44%

Insights on Icu Medical Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 565.95M → 595.82M (in $), with an average increase of 5.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -39.47M → -21.40M (in $), with an average increase of 84.4% per quarter

  • Vs RMD

    In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 41.8%

  • Vs ISRG

    In the last 3 years, Icu Medical Inc has experienced a drawdown of -21.2%, however Intuitive Surgical, Inc. resisted the overall trend and outperformed by 3.9%

Institutional Holdings

  • BlackRock Inc

    13.31%

  • Vanguard Group Inc

    10.52%

  • HHG PLC

    10.00%

  • Fuller & Thaler Asset Management Inc

    6.22%

  • Wellington Management Company LLP

    5.91%

  • JPMorgan Chase & Co

    3.35%

Company Information

icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.

Organization
Icu Medical Inc
Employees
14000
CEO
Mr. Vivek Jain
Industry
Health Technology

Discover More

FAQs